Skip to main content

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 7, Number 4, August 2006

Articles

Favourites:
ADD

Novel Therapies Based on Cationic Antimicrobial Peptides
pp. 229-234(6)
Author: Anne Pereira, H.

Favourites:
ADD

Atherosclerosis and Vascular Disease: Effects of Peptide Mimetics of Apolipoproteins
pp. 235-240(6)
Authors: Garber, David W.; Handattu, Shaila P.; Datta, Geeta; Mishra, Vinod K.; Gupta, Himanshu; Roger White, C.; Anantharamaiah, G. M.

Favourites:
ADD

Emerging Peptide Therapeutics for Inflammatory Diseases
pp. 241-246(6)
Authors: Vally, Maya; Seenu, Sujatha; Pillarisetti, Sivaram

Favourites:
ADD

Recent Advances in the Synthesis of Some Bioactive Peptides and Peptidomimetics
pp. 247-259(13)
Authors: Rajesh, B. M.; Iqbal, Javed

Favourites:
ADD

Novel Delivery Technologies for Protein and Peptide Therapeutics
pp. 261-276(16)
Authors: Shantha Kumar, T. R.; Soppimath, K.; Nachaegari, S. K.

Favourites:
ADD

Accounting for Triplet and Saturation Effects in FCS Measurements
pp. 287-301(15)
Authors: Davis, Lloyd M.; Shen, Guoqing

Favourites:
ADD
Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more